Second- and third-generation beta-blocking drugs in chronic heart failure.

• 1 January 1997
• journal article
• clinical trial
• Published by Springer Nature in Cardiovascular Drugs and Therapy
• Vol. 11  (1) , 291-296
• https://doi.org/10.1023/a:1007748131847

Abstract

Keywords

• DRUGS
• FUNCTIONAL
• BETA
• CHRONIC HEART FAILURE
• SECOND GENERATION
• COMPOUNDS
• TOLERATED